Scilex Holding Future Growth
Future criteria checks 2/6
Scilex Holding is forecast to grow earnings and revenue by 30.8% and 29.4% per annum respectively while EPS is expected to grow by 52.6% per annum.
Key information
30.8%
Earnings growth rate
52.6%
EPS growth rate
| Pharmaceuticals earnings growth | 23.6% |
| Revenue growth rate | 29.4% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 04 Sep 2024 |
Recent future growth updates
Recent updates
Analysts Just Shaved Their Scilex Holding Company (NASDAQ:SCLX) Forecasts Dramatically
Jun 14
It's Down 33% But Scilex Holding Company (NASDAQ:SCLX) Could Be Riskier Than It Looks
Apr 24Scilex Holding Company's (NASDAQ:SCLX) 35% Price Boost Is Out Of Tune With Revenues
Feb 28Risks To Shareholder Returns Are Elevated At These Prices For Scilex Holding Company (NASDAQ:SCLX)
Dec 21Scilex Holding Company's (NASDAQ:SCLX) 56% Dip In Price Shows Sentiment Is Matching Earnings
May 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 100 | -81 | -67 | -30 | 2 |
| 12/31/2025 | 96 | -89 | -111 | -57 | 3 |
| 12/31/2024 | 62 | -102 | -123 | -62 | 1 |
| 6/30/2024 | 51 | -172 | 12 | 12 | N/A |
| 3/31/2024 | 47 | -161 | -4 | -4 | N/A |
| 12/31/2023 | 47 | -167 | -21 | -21 | N/A |
| 9/30/2023 | 45 | -163 | -16 | -16 | N/A |
| 6/30/2023 | 46 | -54 | -19 | -19 | N/A |
| 3/31/2023 | 42 | -45 | -20 | -18 | N/A |
| 12/31/2022 | 38 | -23 | -23 | -21 | N/A |
| 9/30/2022 | 34 | -47 | -29 | -26 | N/A |
| 6/30/2022 | 31 | -81 | -38 | -36 | N/A |
| 3/31/2022 | 33 | -78 | -35 | -35 | N/A |
| 12/31/2021 | 31 | -88 | -29 | -29 | N/A |
| 12/31/2020 | 24 | -48 | -31 | -31 | N/A |
| 12/31/2019 | 21 | -179 | -61 | -60 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SCLX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SCLX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SCLX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SCLX's revenue (29.4% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: SCLX's revenue (29.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SCLX's Return on Equity is forecast to be high in 3 years time